期刊
LIFE-BASEL
卷 11, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/life11080731
关键词
renal carcinoma; ccRCC; pRCC; androgen receptor; AR; AR splice variants; relaxin; RLN2
The study found that clear cell RCC tissues expressed AR and its splice variants more frequently than papillary RCC tissues, with specific AR variants correlating with tumor staging and RLN2 expression in males. Furthermore, the secretion pattern of the proinflammatory cytokine IL-6 was higher in ccRCC than in pRCC, suggesting potential differences in the molecular mechanisms between the two types of kidney cancer.
Background: The role of the androgen receptor (AR) in renal cell carcinoma (RCC) is unclear. We aimed to analyze the expression of AR and its splice variants (SVs) and their correlation with relaxin 2 (RLN2) and cytokines in RCC. Methods: We investigated the expression of RLN2 and AR variants in 25 clear cell RCC (ccRCC) and 9 papillary (pRCC) tumor tissues and the corresponding controls using quantitative PCR and serum RLN2, testosterone and cytokine levels in matched samples using ELISA and chemiluminescent immunometric assay, respectively. Results: ccRCC tissues but not pRCC tissues more frequently expressed AR and the SVs than did normal tissues. All pRCC samples expressed more AR than did ccRCC samples. The highest expression of all AR variants except AR-V12 was found in low-stage tumors, with dominant expression of AR-V7. In males in the ccRCC cohort, the expression of AR-FL, AR-V1 and AR-V3 was significantly correlated with that of RLN2. The secretion pattern of proinflammatory IL-6 was higher in ccRCC than in pRCC. Conclusions: The results highlight additional molecular differences between ccRCC and pRCC, suggesting the influence of external factors on the whole kidney or genetic predispositions to developing certain types of renal cancer, and may support further pathological analysis and studies of targeted hormone therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据